Molina Healthcare, Inc.
NYSE:MOHMedical - Healthcare Plans
-$4.68 today
- Market cap
- $10.78B
- Beta
- 0.80
- P/E (TTM)
- 53.0
- EPS (TTM)
- $3.69
Volume 1.33M
Average 1.37M
MOH Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Molina Healthcare, Inc.NYSE: MOH
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income declines year over year
Q3 FY2026 net income of $38M fell 51.9% year over year, ahead of the -105.4% change in trailing-twelve-month net income. Sequentially, it fell 36.7% from the prior quarter. Over 3 fiscal years it compounded at -15.8% a year.
Context
- Net income amounted to 1.0% of revenue in FY2025, down 1.9 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 12 analysts of $277.35M (-41.2%) for the fiscal year ending Dec 2026, a step up from the -60.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $38M-36.7% QoQ
- Last fiscal yearDec 2025
- $472M-60.0% YoY
- LTMSep 2026
- -$48M-105.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -51.9% | +116.8% | +168.7 pp |
| 1 year | -60.0% | -41.2% | +18.7 pp |
| 3-year CAGR | -15.8% | +14.6% | +30.5 pp |
| 5-year CAGR | +20.4% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 472M USD
- Year-over-year change
- -60.0%
- 4-year CAGR
- -8.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 472M | -60.0% |
| FY2024 | 2024-12-31 | 1.18B | +8.1% |
| FY2023 | 2023-12-31 | 1.09B | +37.8% |
| FY2022 | 2022-12-31 | 792M | +20.2% |
| FY2021 | 2021-12-31 | 659M | — |
Net Income vs competitors
How MOH compares with its peers on the latest reported figures
- MOH's LTM Sep 2026 net income of $48M is the 7th largest of the 8 companies compared; the peer median is $1.24B.
- Its year-over-year change of -105.4% is the 7th highest of 8, against a peer median of -3.9%.
- Net income amounts to 0.1% of revenue for MOH, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $16.67B | -8.1% | -14.0% | 3.7% | |
| LTM Sep 2026 | $6.71B | +2.4% | -2.5% | 2.3% | |
| LTM Jun 2026 | $5.11B | -350.3% | — | 2.6% | |
| LTM Sep 2026 | $5.1B | -7.7% | -2.0% | 2.5% | |
| LTM Sep 2026 | $1.24B | -3.9% | -24.6% | 0.8% | |
| LTM Jun 2026 | $550.93M | +443.4% | -10.1% | 3.6% | |
| LTM Sep 2026 | $48M | -105.4% | -15.8% | 0.1% | |
| LTM Mar 2026 | $19.79M | +121.8% | -83.1% | 0.5% | |
| Peer median (excluding MOH) | $1.24B | -3.9% | -12.0% | 2.5% | |
Competitors are the stored peer set for MOH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 659M | 792M | 1.09B | 1.18B | 472M |
| Depreciation & Amortization | 131M | 176M | 171M | 186M | 195M |
| Deferred Income Tax | (24M) | (66M) | (31M) | 53M | 43M |
| Stock-Based Compensation | 72M | 103M | 115M | 116M | 47M |
| Change in Working Capital | 1.22B | (448M) | 314M | (898M) | (1.29B) |
| Accounts Receivables | (415M) | (95M) | (778M) | (78M) | (145M) |
| Inventory | 0 | 0 | 778M | 0 | 0 |
| Accounts Payables | 138M | 55M | 328M | 115M | (221M) |
| Other Working Capital | 1.5B | (408M) | (14M) | (935M) | (923M) |
| Other Non-Cash Items | 58M | 216M | 2M | 8M | (3M) |
| Operating Cash Flow | 2.12B | 773M | 1.66B | 644M | (535M) |
| Capital Expenditures | (77M) | (91M) | (84M) | (100M) | (101M) |
| Acquisitions (Net) | (129M) | (134M) | (3M) | (344M) | (245M) |
| Purchases of Investments | (2.71B) | (1.91B) | (1.43B) | (1.13B) | (751M) |
| Sales of Investments | 1.33B | 1.4B | 772M | 1.11B | 1.41B |
| Other Investing Activities | (63M) | (50M) | 4M | 1M | 1M |
| Investing Cash Flow | (1.65B) | (790M) | (744M) | (464M) | 312M |
| Debt Repayment | 17M | 0 | 0 | 740M | 838M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (128M) | (400M) | (60M) | (1B) | (1B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (19M) | (41M) | 2M | (87M) | (8M) |
| Financing Cash Flow | (183M) | (441M) | (58M) | (347M) | (170M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 283M | (458M) | 860M | (167M) | (393M) |
| Free Cash Flow | 2.04B | 682M | 1.58B | 544M | (636M) |
Molina Healthcare, Inc.
NYSE:MOH
Intrinsic Alpha fair value
Locked
Current Price
$206.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.